Stryker showcases multiple innovative medical technology products at the 7th CIIE
塞江南
发表于 4 小时前
3993
0
0
On November 5th, the 7th China International Import Expo (CIIE) kicked off in Shanghai. Stryker, one of the world's leading medical technology companies, unveiled nearly 40 innovative products and solutions this year, showcasing its cutting-edge technological achievements in the field of medical devices. This includes 6 innovative products that made their debut to the public at the CIIE, as well as 2 latest innovative products that have been implemented and transformed into products.
This year marks Stryker's fourth active participation in the China International Import Expo, with a total of six exhibition areas showcasing cutting-edge innovative technologies and products in the fields of joint and Mako robots, endoscopes, power, trauma, nerve intervention, and emergency medical care.
It is reported that Stryker showcased a total of six Chinese debut products at this year's CIIE, including the Mako Smart Joint Robot Total Hip Arthroplasty (THA) 4.0 system, which adds "Functional Hip Preoperative Planning" and "Dynamic Impact Simulation" functions, and improves surgical accuracy and hip joint stability; MDM dual action total hip joint system that can provide good stability and effectively reduce the risk of hip dislocation after hip surgery; SPY PHI open fluorescence imaging system; IsoTour anti pressure ulcer turning mattress with honeycomb structure design and "microclimate management" that can effectively prevent the occurrence of pressure ulcers; The Stair Pro stretcher, which uses Stryker's patented technology, Stair TREAD, to help patients reliably and controllably descend stairs; MedporTSI porous polymer polyethylene repair material is used to repair saddle bone defects in various nasal canal surgeries.
In addition to the first exhibition and showcase of the exhibits, Stryker also brought two medical technologies that have achieved the transformation of "exhibits into commodities". For example, InSpace can absorb implantable balloons, which were approved for marketing in China in July this year; Sonopet iQ is a newly upgraded ultrasound surgical suction system that combines both soft and hard functions. It can simultaneously meet the three major functions of soft tissue suction, bone tissue polishing, and cutting, greatly improving the efficiency and safety of brain tumor and orthopedic surgery. At this year's CIIE, Stryker will officially release this product.
The CIIE is a high-level platform for opening up to the outside world and promoting high-level cooperation and development, "said Zhang Shaobin, General Manager of Stryker China. Participating in the CIIE for four consecutive years not only gives Stryker the opportunity to showcase our proud leading medical technology and products on this broad stage, but also helps us exchange ideas, build cooperative relationships, and explore opportunities for common growth with all sectors on this excellent platform.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
-
アップル(AAPL)は現地時間10月31日、9月28日までの2024年第4四半期の業績を発表し、同四半期の売上高は前年同期比6%増の949億3000万ドル、純利益は同36%減の147億3600万ドルだった。 純利益の下落は主に102億ドル ...
- 亲亲宝宝贝贝贾
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
【英偉達の需要が高すぎる?SKハイニックス:黄仁勲がHBM 4チップの6カ月前納入を要求!】SKハイニックスの崔泰源(チェ・テウォン)会長は月曜日、インビダーの黄仁勲(ファン・インフン)CEOが同社の次世代高帯域 ...
- 琳271
- 昨天 17:54
- 支持
- 反对
- 回复
- 收藏
-
ファイザーが前立腺がんを治療する革新薬テゼナ& ;reg;(TALZENNA®,一般名:トルエンスルホン酸タラゾールパーリカプセル)は2024年10月29日に国家薬品監督管理局(NMPA)の承認を得て、HRR遺伝子突然変異 ...
- 什么大师特
- 半小时前
- 支持
- 反对
- 回复
- 收藏
-
南方財経は11月5日、中央テレビのニュースによると、現地時間11月5日、米ボーイング社のストライキ労働者が59%の投票結果で新たな賃金協定を受け入れ、7週間にわたるストライキを終えた。ストライキ労働者は11月12 ...
- Dubssgshbsbdhd
- 2 小时前
- 支持
- 反对
- 回复
- 收藏